本文へスキップ
Likelier

行動 vs. 不行動:各選択の数値

腎不全に対する透析を開始する vs. 保存的(非透析)管理を選択する

行動した場合

透析を始める

19%

行動しなかった場合

保存的(非透析)治療を選ぶ

直接の測定はありません

少なくとも1つの数値は間接的な推定値であり、実際に測定した後悔の割合ではありません。各数値の算出方法は下に記載しています。


健康

最終確認 2026-05-04

証拠の質 3.75/5

8次元のレビュー評価。基準は 品質ルーブリック 。各次元は1〜5で評価。

D1 出典の検証
3/5
D2 出典の権威性と独立性
4/5
D3 後悔率の正確性
3/5
D4 出典の比較可能性
4/5
D5 ギロヴィッチ・パターン
5/5
D6 文章の質
4/5
D7 注意事項の完全性
4/5
D8 サンプルの質
3/5
平均 3.75/5
A flat vector illustration of a dialysis machine on one side and a simple hospital bed on the other
間接データ:この決断については、少なくとも1つの数値が、後悔を直接尋ねた調査ではなく、結果、満足度、意向といった間接的な指標、または編集部による推定に基づいています。各数値の算出方法は、下の各選択肢の注記に記載しています。

行動した場合

透析を始める

19%

維持透析患者の約19%が透析を開始するという決定を後悔している。後悔は、生存利益が最も控えめな高齢・高併存疾患の患者に集中する

末期腎不全で透析を開始した75歳以上の成人、特に併存疾患の負担が高い者(Davison 2010; Morton et al. 2012)

透析開始から12か月以内

行動しなかった場合

保存的(非透析)治療を選ぶ

直接の測定はありません

この選択肢について数値を示す出典がないため、数値は表示していません。

緩和支援を伴う保存的管理を選んだ末期腎不全の75歳以上の成人(Murtagh et al. 2011; Davison らの質的研究)

遡及的;患者と代理者による報告

各選択の数値(何を測ったかはページに明記)

関連する決断

意味的に類似する決断 — 同じ領域、異なるトレードオフ。

健康

積極的化学療法 vs. 早期緩和ケア

行動と不作為:各選択の情報源

健康

MAID vs. ホスピスケア

各選択の数値(何を測ったかはページに明記)

健康

事前指示書の作成タイミング

各選択の数値(何を測ったかはページに明記)

健康

代替医療のみ vs. 標準腫瘍治療

各選択の数値(何を測ったかはページに明記)

健康

長寿追求 vs 老化受容

各選択の数値(何を測ったかはページに明記)

健康

運動習慣

各選択の数値(何を測ったかはページに明記)

family直接

家族の臓器提供を承認 vs. 拒否

この選択を後悔した割合

不作為が優勢

不作為の後悔が6.8倍高い

family

老人ホーム vs. 在宅介護

各選択の数値(何を測ったかはページに明記)

この決断の背後にあるリスク

この選択の根底にある確率。

For elderly patients over 75 with end-stage renal disease and high comorbidity burden, dialysis and conservative management (symptom-focused non-dialytic care) are genuinely contested alternatives. Da Silva-Gane et al.’s 2012 CJASN study of 170 patients with advanced kidney failure found an adjusted median survival of 1317 days on haemodialysis versus 913 days on conservative kidney management — about a 13-month advantage — with broadly comparable life-satisfaction scores. Murtagh et al.’s 2007 study of 129 patients aged 75 and over found that this survival advantage narrows sharply with comorbidity and is lost altogether in patients with high comorbidity scores, especially ischaemic heart disease. Against that modest, burden-laden benefit, Saeed et al.’s 2019 survey of 423 maintenance dialysis patients found that nearly 19% regretted their decision to start dialysis — driven by treatment burden (three weekly sessions of three to four hours each, strict dietary and fluid restrictions, fatigue) set against the perceived benefit in the context of functional status and life goals. Regret is concentrated in exactly the elderly, high-comorbidity group where the survival benefit is smallest.

Regret among patients who chose conservative management has no direct measurement.

This entry concerns a specific, bounded population: elderly, frail, high-comorbidity ESRD patients. For younger patients or those with lower comorbidity burden, dialysis provides substantially greater survival benefit.

出典: 行動

根拠台帳

以下の各数値は各出典が報告した内容であり、引用した原文の抜粋と算出方法を記載しています。リンクをクリックして直接確認できます。

3/3 件の出典が引用元と一字一句一致することを独立して検証済み

  1. [1] Clinical Nephrology — Patients' perspectives on dialysis decision-making and end-of-life care 検証済み
    Patients' perspectives on dialysis decision-making and end-of-life care
    統計値
    Nearly 19% of maintenance dialysis patients regretted their decision to start dialysis (Saeed et al., n=423 surveyed)
    抜粋
    “"Nearly 19% of respondents regretted their decision to start dialysis." ”
    出典データ
    2019-05-01
    アクセス日
    2026-06-30
    検証
    グラウンディング監査の際、抜粋を引用元から独立して再取得し、原文と一字一句一致することを確認しました。
    計算過程
    Saeed F, Sardar MA, Davison SN, Murad H, Duberstein PR, Quill TE. Clin Nephrol 2019;91(5):294-300 (PMID 30663974). Cross-sectional survey of 423 maintenance dialysis patients (Cleveland, OH). Directly measured dialysis decisional regret: nearly 19% regretted starting dialysis. This 19% is used as the action-side regret_rate. Regret is higher in elderly/high-comorbidity subgroups, where the survival benefit of dialysis is most modest; for younger, healthier ESRD patients regret would be lower.
  2. [2] Clinical Journal of the American Society of Nephrology (CJASN) — Quality of Life and Survival in Patients with Advanced Kidney Failure Managed Conservatively or by Dialysis 検証済み
    Quality of Life and Survival in Patients with Advanced Kidney Failure Managed Conservatively or by Dialysis
    統計値
    Adjusted median survival advantage of dialysis over conservative kidney management was ~404 days (~13 months); quality-of-life and life-satisfaction scores were broadly comparable between groups (Da Silva-Gane et al., n=170)
    抜粋
    “"median survival from recruitment was 1317 days in HD patients (mean of 326 dialysis sessions) and 913 days in CKM patients. … Patients choosing CKM maintained quality of life. Adjusted median survival from recruitment was 13 months shorter for CKM patients than HD patients." ”
    出典データ
    2012-12-01
    アクセス日
    2026-06-30
    検証
    グラウンディング監査の際、抜粋を引用元から独立して再取得し、原文と一字一句一致することを確認しました。
    計算過程
    Da Silva-Gane M, Wellsted D, Greenshields H, Norton S, Chandna SM, Farrington K. Clin J Am Soc Nephrol 2012;7(12):2002-2009 (PMC3513739). Prospective study of 170 patients with advanced kidney failure choosing dialysis or conservative kidney management (CKM). Adjusted median survival 1317 days (HD) vs 913 days (CKM) — a ~13-month advantage for dialysis, with comparable life-satisfaction scores. The modest, burden-laden survival benefit explains why a meaningful minority of dialysis starters (Saeed: ~19%) come to regret the decision. This study measures survival/QoL, not regret directly.
  3. [3] National Kidney Foundation — Hemodialysis 検証済み
    Hemodialysis
    統計値
    Standard in-center hemodialysis is administered 3 times per week, with each session lasting 3 to 4 hours
    抜粋
    “"Treatments at a dialysis center are usually done 3 times a week, each taking 3 to 4 hours to complete." ”
    出典データ
    2024-04-26
    アクセス日
    2026-07-03
    検証
    グラウンディング監査の際、抜粋を引用元から独立して再取得し、原文と一字一句一致することを確認しました。
    計算過程
    National Kidney Foundation patient-education page, last updated 2024-04-26. Cited as the basis for the in-center treatment schedule (3 sessions/week, 3-4 hours each) referenced in the body prose as treatment-burden context for why a meaningful minority of dialysis starters (Saeed et al. 2019: ~19%) regret the decision. Background/context only; not used in regret_rate arithmetic.

出典: 不作為

根拠台帳

以下の各数値は各出典が報告した内容であり、引用した原文の抜粋と算出方法を記載しています。リンクをクリックして直接確認できます。

1/2 件の出典が引用元と一字一句一致することを独立して検証済み

  1. [1] BMC Nephrology — Older patients' experiences with a shared decision-making process on choosing dialysis or conservative care for advanced chronic kidney disease: a survey study
    Older patients' experiences with a shared decision-making process on choosing dialysis or conservative care for advanced chronic kidney disease: a survey study
    統計値
    Of patients who chose conservative care, 0/23 (0%) reported lingering doubts about their treatment decision (vs 12/70, 17%, of dialysis patients; P=0.03); 91% of conservative-care patients were satisfied with the decision
    抜粋
    “"Do you still have doubts about your treatment decision? … 12/70 (17%) 0/23 (0%) 0.03" ”
    出典データ
    2019-07-01
    アクセス日
    2026-06-30
    計算過程
    Verberne WR, et al. BMC Nephrol 2019;20:264 (PMC6635995). Survey study of 99 patients (75 dialysis, 24 conservative care). Directly measured decision doubt and satisfaction: 0/23 (0%) of conservative-care patients still had doubts about their treatment decision versus 17% of dialysis patients (P=0.03); satisfaction with the decision was 91% (CC) vs 87% (dialysis). Conservative-care patients reported the lowest decisional regret of the two groups — the basis for a near-zero inaction-side regret rate among those who chose conservative care after shared decision-making.
  2. [2] Nephrology Dialysis Transplantation — Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 検証済み
    Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5
    統計値
    In patients ≥75 with CKD stage 5, the survival advantage of dialysis over conservative care narrows sharply with comorbidity and is lost in those with high comorbidity scores, especially ischaemic heart disease (Murtagh et al., n=129)
    抜粋
    “"However, this survival advantage was lost in those patients with high comorbidity scores, especially when the comorbidity included ischaemic heart disease." ”
    出典データ
    2007-07-01
    アクセス日
    2026-06-30
    検証
    グラウンディング監査の際、抜粋を引用元から独立して再取得し、原文と一字一句一致することを確認しました。
    計算過程
    Murtagh FEM, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE. Nephrol Dial Transplant 2007;22(7):1955-1962 (PMID 17412702). Retrospective survival comparison of 129 patients ≥75 with CKD stage 5 (52 dialysis, 77 conservative). 1- and 2-year survival 84%/76% (dialysis) vs 68%/47% (conservative); the survival advantage of dialysis was lost in high-comorbidity / ischaemic-heart-disease patients. This is the clinical context for why elderly high-comorbidity patients can reasonably choose conservative care with low regret. Measures survival, not regret directly.

注意事項

This entry applies specifically to elderly patients (≥75) with high comorbidity burden where the dialysis-vs-conservative choice is genuinely contested clinically. For younger patients or those with lower comorbidity burden, dialysis provides substantially greater survival benefit and lower regret. The action-side ~19% regret (Saeed et al. 2019, all maintenance dialysis patients) understates the figure for the elderly high-comorbidity subgroup, where the treatment burden-to-benefit ratio is least favourable. The inaction side has no direct measurement of regret. Conservative management requires access to good palliative/symptom support.

生データ: /api/decisions.json

このデバイスで最近見た項目